MBOT Microbot Medical Inc: רווח למניה ב-12 החודשים האחרונים

Microbot Medical Inc. (MBOT) develops ultra-small robots for minimally invasive surgeries, expanding its presence in clinics. This chart reflects that the asset value on GURU.Markets is 53.80. Profit and cash flow growth depend on the implementation of patent-protected disposable components. Meanwhile, operations in the US and Israel hold humanitarian status, which eliminates the impact of trade conflicts and ensures legal stability.

Year-over-year (YoY) EPS growth (TTM) reflects the dynamics of net income per share over the last twelve months relative to the previous year. Professionals utilize the relative YoY TTM EPS growth metric to assess capital generation efficiency amid tight monetary policy. Analyzing this curve allows for the identification of fundamental asset undervaluation. For Microbot Medical Inc. (MBOT), which is focused on prototypes, this metric highlights an investment stage where operating expenses outweigh environmentally neutral production.